M&A Deal Summary

CTI Molecular Imaging Acquires Concorde Microsystems

On July 1, 2004, CTI Molecular Imaging acquired medical products company Concorde Microsystems for 41M USD

Acquisition Highlights
  • This is CTI Molecular Imaging’s 1st transaction in the Medical Products sector.
  • This is CTI Molecular Imaging’s largest (disclosed) transaction.
  • This is CTI Molecular Imaging’s 1st transaction in the United States.
  • This is CTI Molecular Imaging’s 1st transaction in Tennessee.

M&A Deal Summary
Date 2004-07-01
Target Concorde Microsystems
Sector Medical Products
Buyer(s) CTI Molecular Imaging
Deal Type Add-on Acquisition
Deal Value 41M USD
Advisor(s) Edge Healthcare Partners LLC (Financial)

Target

Concorde Microsystems

Knoxville, Tennessee, United States
oncorde initiated efforts to commercialize microPET, a Positron Emission Tomography (PET) scanner designed for small animal imaging.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CTI Molecular Imaging

Knoxville, Tennessee, United States
Category Company
Founded 1983
Sector Medical Products
Employees963
DESCRIPTION

CTI Molecular Imaging, Inc. is a provider of products and services for the positron emission tomography (PET) market. CTI is a supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, cardiac disease and neurological disorders.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Tennessee) 1 of 1
Country (United States) 1 of 1
Year (2004) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal